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Short Communication
The actin-bundling protein fascin is overexpressed in colorectal
adenomas and promotes motility in adenoma cells in vitro
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BACKGROUND: Fascin is overexpressed in many cancers, including colorectal, but its role in the malignant transformation of benign
colorectal adenomas is unclear.
METHODS: Immunohistochemical analysis of fascin expression was carried out in resected human colorectal adenoma specimens.
The effects of forced overexpression of fascin on adenoma cell motility were also analysed.
RESULTS: We show fascin overexpression in adenomas increasing with tumour size, histological type, and degree of dysplasia and
increased cell motility in adenoma cell lines following fascin transfection.
CONCLUSION: These data suggest an important role for fascin in the malignant progression of colorectal tumours.
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Colorectal cancer development is widely accepted to involve the
multifaceted progression of a benign lesion (adenoma) to invasive
adenocarcinoma (hereafter referred to as ‘carcinoma’) by acquisi-
tion of a migratory, and ultimately invasive phenotype (Muto et al,
1975). The precise nature of the changes required for the
malignant progression of adenomas remain poorly understood
but prognosis is widely accepted to correlate with both the physical
size and histological type of the adenomatous polyp, as well as the
degree of cellular dysplasia displayed by the tumour cells (Muto
et al, 1975).
The changes in motile behaviour demonstrated by tumour cells
require dynamic rearrangements in the actin cytoskeleton, which
are governed by multiple actin-binding proteins (Matsudaira,
1994). The 55kDa fascin-1 protein (hereafter be referred to simply
as fascin) localises to the core actin bundles of spikes and filopodia
at the leading edge of migratory cells, and has been shown to
increase migration in several cell types (Adams, 2001; Kureishy
et al, 2002). There now exists a plethora of reports showing a
general trend across epithelial tissues with fascin being absent
from normal epithelium and present in tumours of the same tissue
origin (Hashimoto et al, 2005).
We have previously shown that fascin is absent from normal
colorectal epithelium but overexpressed in colorectal carcinomas
(Sawhari et al, 2003). Two recent studies have demonstrated that
fascin expression correlates with a poor prognosis in colorectal
cancers (Hashimoto et al, 2006; Puppa et al, 2007). Hashimoto
et al. (2006) found no correlation between the genetic origin of
colorectal adenomas (FAP or sporadic) and fascin expression
(Hashimoto et al, 2006). However, to date, no study has been
reported analysing the expression and distribution of fascin in
benign colorectal adenomas in relation to the clinical risk factors
associated with malignant tumour progression.
To understand the role of a gene during tumourigenesis, it is
important to know at what stage it becomes deregulated. In the
study presented here, we sought to determine this potential
relationship between fascin expression and malignant progression
in colorectal adenomas. We performed immunohistochemistry for
fascin on colorectal adenoma specimens graded for the risk factors
associated with malignant potential, namely polyp size, histologi-
cal type and the degree of dysplasia. To corroborate these findings
we studied fascin expression in colorectal adenoma-derived cell
lines and determined the effect of fascin overexpression on cell
motility in these non-malignant cells.
MATERIALS AND METHODS
Immunohistochemistry
Anonymised, archival, paraffin-embedded material was obtained
from the files of the Department of Histopathology, Bristol Royal
Infirmary following ethical approval (04/Q2003/49). A total of 64
surgically resected colorectal adenomas were categorised on the
basis of polyp size, histological type and the degree of dysplasia as
outlined in Table 1. We also examined 10 samples of normal
colorectal mucosa.
Fascin was detected using a mouse monoclonal antibody
(Dako-Cytomation, Glostrup, Denmark) as previously described
(Jawhari et al, 2003). Negative controls had no primary antibody
applied.
Stained samples were scored by two independent observers (DQ
and NB) in terms of the proportion of epithelial cells staining
positive (1 for o20%, 2 for 20–80% and 3 for 480%) and also the
intensity of epithelial staining relative to that observed in adjacent
endothelial cells (0, 1, 2, 3 for negative, weak, moderate and strong,
Received 4 June 2009; revised 22 July 2009; accepted 1 August 2009;
published online 8 September 2009
*Correspondence: D Qualtrough; E-mail. david.qualtrough@bristol.ac.uk
British Journal of Cancer (2009) 101, 1124–1129





















srespectively). The adenomas were also scored for focal fascin
intensity around the tumour stalk.
Cell lines
The adenoma cell lines AA/C1, AN/C1, BH/C1 and RG/C2 have
been described previously (Paraskeva et al, 1984, 1989). All of the
adenoma-derived cell lines are anchorage-dependent and are non-
tumorigenic in athymic-nude mice (Paraskeva et al, 1989). HT29
and SW480 were derived from sporadic colonic adenocarcinomas
(Fogh and Trempe, 1975; Leibovitz et al, 1976).
Table 1 Categorisation of colorectal adenoma samples (n¼64) used for
immunohistochemical study of fascin expression showing the number of
specimens in each category
Histological type Degree of dysplasia
Adenoma size Tubular Tubulovillous Mild Moderate Severe
Small (o0.5cm) 12 2 8 6 0
Medium (0.5–3.5cm) 8 22 3 23 4











Figure 1 Fascin is overexpressed in colorectal adenomas: immunoreactivity correlates with tumour size, histology, and dysplasia and is focussed towards
the stalk. Fascin immunoreactivity was detected in specimens of human colorectal adenomas by immunoperoxidase staining. (A and B) Normal colorectal
mucosa showing positive staining in the stroma (arrowheads indicates endothelial cells in B),  100 and  400 magnifications, respectively. (C) The contrast
in fascin immunoreactivity between a large tubulovillous adenoma with severe dysplasia and the adjacent non-neoplastic tissue (labelled),  100
magnification. (D, E and F) Representative figures showing fascin immunoreactivity in a small tubular (D,  100), medium tubulovillous (E,  50) and large
tubulovillous (F,  25) adenoma. (G and H) Higher magnification images to show the subcellular distribution of fascin immunoreactivity within the adenoma
epithelium: G, a medium tubulovillous adenoma with mild dyspplasia,  400; H, medium tubular adenoma with moderate dysplasia,  400 (arrowheads,
endothelial cells in G). (I, J and K) Images showing the focal localisation of fascin expression around the adenoma stalk (I, medium tubulovillous adenoma,
 100; J, medium tubular adenoma,  25; K, large tubulovillous adenoma,  50).
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Samples of 2 10
6 cells were prepared for western blotting as
described by Qualtrough et al (2007). A mouse monoclonal
antibody raised against fascin was obtained from Dako (Dako-
Cytomation, Carpinteria, CA, USA). Blots were subsequently
probed with anti-a-tubulin (Sigma, Poole, UK) to show equal
sample loading.
Transfection and in vitro migration assays
For fascin overexpression studies, cells were seeded in triplicate in
25cm
2 flasks and grown to 90% confluency. Cells from each cell
line were then transfected with either 10mg pcDNA3 (Invitrogen,
Paisley, UK) or 10mg pcDNA3/human fascin-1 (Jawhari et al, 2003)
using Transfast (Promega, Southampton, UK) following the
manufacturers instructions, or medium changed as untransfected
controls. The pcDNA3/human fascin-1 plasmid was a kind gift
from Dr Jo Adams (University of Bristol). After 24h transfection,
the cells were prepared for motility assays with a sample being
simultaneously prepared for western blotting to confirm the
efficacy of transfection.
Cell migration assays were carried out using a transwell filter
migration assay as previously described (Qualtrough et al, 2007).
In this instance, the lower chamber was filled with calcium free-
DMEM supplemented with 5% FBS to act as an attractant. After a
24h incubation and staining with haematoxylin, cells on the lower
filter surface were considered migratory and counted in 10 fields at
 20 magnification.
RESULTS
Fascin expression correlates with adenoma size,
histological type and the degree of dysplasia, and is largely
focussed around the polyp stalk
Fascin immunohistochemistry was performed on 10 samples of
normal colorectal mucosa and 64 colorectal adenomas categorised
as shown in Table 1. Figure 1A and B show fascin immuno-
reactivity in normal colonic mucosa in longitudinal and transverse
sections of the crypt-cuff axis, respectively. Positive staining was
observed in the lamina propria, within endothelial cells (arrowed
in Figure 1B and also Figure 1G), fibroblasts, and infiltrating
lymphocytes. The epithelial tissue was uniformly negative for
fascin.
Immunohistochemical analysis of colorectal adenomas showed
that fascin expression was upregulated in the tumour epithelium
and correlated with tumour size, tubulovillous histology and the
degree of dysplasia. Figure 1C demonstrates the difference in
fascin immunoreactivity between normal epithelium and adeno-
matous cells.
Of the 64 adenomas examined, 47 exhibited positive epithelial
fascin immunoreactivity representing 43% of small (o0.5cm),
77% of medium (05–3.5cm) and 90% of large (43.5cm)
adenomas. Statistical analysis of the data shows a significant
correlation between polyp size and both the proportion of
positive epithelial cells and the intensity of fascin immuno-
reactivity (scored relative to the endothelium), see Table 2.
Figure 1D, E and F show representative examples of fascin staining
in small, medium and large adenomas, respectively. These pictures
clearly show the increasing proportion of positively stained
epithelial cells and intensity of fascin staining in relation to
polyp size.
Observation of the adenomas at higher magnification showed
a cytoplasmic subcellular distribution as shown in Figure 1G
and H with no nuclear staining. In Figure 1G, the strongly
positive endothelial cells of a blood vessel can be clearly seen
(arrowed) adjacent to an epithelial gland showing mild
dysplasia and cytoplasmic fascin. Figure 1H shows a moderately
dysplastic epithelial gland with fascin immunoreactivity in the
cytoplasm but more intense than the mildly dysplastic adenoma
shown in Figure 1G. Statistically across the sample group, the
proportion of fascin-positive tumour epithelium and staining
intensity correlated significantly (Table 2) with increasing
dysplasia (mild, moderate or severe) exhibited by the adenoma
(Figure 1G and H).
The adenoma samples studied were also graded according to
histological type (tubular or tubulovillous) with a villous
component observed in 17, 64 and 100% of small, medium and
large adenomas, respectively (Table 1). Positive fascin immuno-
reactvity was found in 80% of tubulovillous adenomas (Figure 1F
and K) compared with 55% in the tubular group (Figure 1D and J).
Table 2 Statistical correlation (Kendall’s tau B) between fascin immunoreactivity and tumour size, histological type and degree of dysplasia in colorectal
adenomas
Proportion of positive epithelial cells Intensity of epithelial staining Focal staining around stalk
Adenoma characteristics o20% 20–80% 480% 0 1 2 3 Yes No
Polyp size
S1 3 1 0 8 3 2 1 3 1 1
M 22 5 3 7 6 2 15 20 10
L 12 6 2 2 1 6 11 15 5
TauB 0.254* 0.344** 0.344**
Histology
T1 9 0 1 9 4 1 6 7 1 3
TV 28 12 4 9 3 8 24 31 13
TauB 0.288* 0.287* 0.335**
Dysplasia
Mild 10 0 1 7 1 1 2 1 10
Mod 35 9 2 9 7 9 21 33 13
Sev 3 3 1 0 0 1 6 6 1
TauB 0.244* 0.448** 0.437**
Numbers given indicate the number of samples in each category and the Kendall’s TauB correlation coefficient (between  1 and +1) The statistical significance of the correlation
is indicated as follows: *P¼o0.05, **P¼o0.01. Polyp size: smallr0.5cm, medium0.5–3.5cm, largeZ3.5cm; histology: tubular (T) or tubulovillous (TV); dysplasia: mild,
moderate, severe.
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sOnly 5% of tubular adenomas contained more than 20% fascin-
positive epithelial cells compared with 34% of the tubulovillous
group.
The most intense epithelial staining for fascin, particularly in the
medium and large adenomas, tended to be focussed towards the
stalk of the polyp (Figure 1I, J and K). Only 14% of small adenomas
displayed this localisation, whereas 50% of medium and 85% of
large adenomas showed focal staining towards the tumour stalk
and this trend with polyp size was found to be statistically
significant (Table 2).
Western blotting was used to assess the native levels of fascin
expression in adenoma-derived cell lines compared with widely
used carcinoma-derived cell lines (Figure 2). These cell lines are
anchorage-dependent, non-tumourigenic, and non-invasive and
therefore provide a model for the study of specific genes in
adenoma to carcinoma progression (Paraskeva et al, 1984, 1989;
Brunton et al, 1997).
Fascin expression was not clearly detected under these
conditions in BH/C1 and RG/C2, even though the blots shown
represent a high level of exposure. However, the AA/C1 and AN/C1
adenoma cell lines showed readily detectable levels of fascin
expression but much lower than those observed in the carcinoma-
derived cell lines HT29 and SW480.
Fascin expression increases motility in colorectal adenoma
cells in vitro
Fascin expression in colorectal adenomas was found to relate to
polyp size, histology and dysplasia in a manner consistent with a
role in increasing malignant potential. Malignant transformation
of tumours requires increased cell motility and we therefore used
an in vitro model to determine whether fascin increases migration
of benign colorectal adenoma cells.
In vitro migration assays were carried out on three adenoma-
and two carcinoma-derived cell lines 24h after transient trans-
fection with either fascin or an empty vector control (Figure 3A).
We have previously shown that fascin overexpression stimulates
motility in the SW1222 cell line (Jawhari et al, 2003). Western blots
were carried out to show the efficacy of transfection (Figure 3B).
Densitometric analysis of the western blots was performed and
fold control increases of 2.36, 2.78, 4.04 and 1.55 for the AA/C1,
AN/C1, RG/C2 and HT29 cell lines were observed, respectively.
A further 24h after transfection, cell migration was signi-
ficantly increased by fascin overexpression compared with vector
controls in each of the adenoma cell lines tested (AA/C1, AN/C1
and RG/C2), with a comparative response in the carcinoma-
derived cell line HT29.
DISCUSSION
Despite the continued broadening of our knowledge base, tumour
spread results in 90% of all cancer deaths, and around half of
patients presenting with colorectal cancer have advanced disease at
clinical presentation (Young and Rea, 2000; Sporn, 1996). There-
fore, there is a continuing need for new targets for disease
management and a greater understanding of malignant progres-
sion required.
The dynamic rearrangements required in the cytoskeleton to
allow cell motility and ergo tumour invasion require the action of
multiple proteins including actin cross-linkers, such as fascin. The
expression of fascin has been shown to be low or absent in the
normal epithelium of a number of tissues, but deregulated in
cancer (Hashimoto et al, 2005). We, and others, have recently
shown that fascin expression is readily detected in the epithelial
component of colorectal carcinomas (Jawhari et al, 2003;
Hashimoto et al, 2006; Puppa et al, 2007). These data show that
the expression of fascin represents a phenotypic change in
colorectal carcinomas and that fascin is associated with a poorer
prognosis in colorectal cancer patients (Hashimoto et al, 2006;
Puppa et al, 2007). To understand fully the role of fascin in
colorectal tumorigenesis, it is important to determine at what stage
it becomes deregulated. Furthermore, no study has reported on the
potential use of fascin as a biomarker for malignant progression in
the earlier stages of colorectal tumourigenesis; for example, this
type of marker could prove useful in determining the level of
clinical follow-up required in patients following polypectomy. In
this study, we sought to determine whether fascin has a role in
malignant progression. Hashimoto et al (2006) found altered fascin
expression in colorectal adenomas, but found no difference in
fascin expression between FAP and sporadic tumours. In the study
presented here, we have assessed a cohort of adenomas for fascin
expression and correlated these data with the size, histology and
dysplasia in the tumours. These three characteristics are known to
be related to one another, but are also thought to be the crucial
criteria for determining the malignant potential of an adenoma
(Hamilton and Aaltonen, 2001). These factors have not previously
been described in relation to fascin expression in colorectal
adenomas.
Our data not only show a consistent overexpression of fascin in
adenomas compared with normal tissue, but also significant
positive correlations between the expression of fascin with tumour
size, histology, dysplasia, both in terms of the proportion of
the epithelium staining positively and the intensity of immuno-
reactivity. The strongest correlation was observed between fascin
expression and the degree of dysplasia.
Analysis of fascin expression in adenoma-derived cell lines
could also be considered to show the same relationship with
adenoma size seen in vivo. If graded by the size of the original
polyp from which they were derived, the BH/C1 (o0.5cm), RG/C2
(1–2cm), AN/C1 (1–2cm) and AA/C1 (3–4cm) cell lines
(Paraskeva et al, 1984, 1989) show a direct correlation with the
level of fascin expression.
The observation of fascin immunoreactivity focussed around
the stalk of the polyps augments the idea that fascin could
be important in malignant progression, as this is the potential
site for malignant invasion. This localisation of fascin at the point
of maximal contact with the underlying mesenchyme also allows
us to speculate on the mechanism of fascin regulation, raising
the possibility of epithelial–mesenchymal crosstalk directly
affecting fascin expression. If true, this regulation may occur
through alterations in the extracellular matrix deposited by
the epithelium and the underlying mesenchyme, or through the
secretion of paracrine factors affecting fascin transcription in the
epithelial cells.
The functional consequence of fascin expression in adenomas















Figure 2 Fascin is more highly expressed in colorectal carcinoma
cell lines compared with those derived from adenomas. Western
blot analysis of fascin expression in cell lines derived from colorectal
adenomas (AA/C1; AN/C1; BH/C1; and RG/C2) and carcinomas
(HT29 and SW480). This blot is representative of three independent
experiments. The blot was reprobed for a-tubulin to show even sample
loading.
Fascin in colorectal tumour progression
D Qualtrough et al
1127




















sThe adenoma cell lines represent benign tumours and are
anchorage-dependent and non-tumorigenic. The role of fascin in
the pre-malignant stages of colorectal tumorigenesis has not
previously been studied in vitro. Fascin overexpression promoted
cell motility in all the cell lines tested. The acquisition of motile
behaviour is necessary for localised invasion and therefore
malignancy. Therefore, the observed focal expression of fascin
around the stalk of large adenomas in vivo, combined with the
promotion of cell motility in vitro, implies that fascin over-
expression may be important in the malignant progression of
colorectal tumours.
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Figure 3 Fascin overexpression increases cell motility in both colorectal adenoma- and carcinoma-derived cell lines. (A) The forcible overexpression of
fascin by transient transfection in adenoma- and carcinoma-derived cell lines increases cell motility in vitro (compared with vector-only control), as measured
by Boyden chamber assay using 5% FBS as an attractant (***Po0.001 fascin transfected vs empty vector control). Three independent experiments were
carried out in triplicate and the data are expressed as the mean±s.e.m. (B) Also shown are western blots performed to show the overexpression of fascin
in the transfected cells. F¼pCDNA3-fascin expression plasmid; V¼vector control.
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